Works in Basic & Clinical Pharmacology & Toxicology, 2024, Vol 134, Issue 5


Results: 16
    1
    2
    3
    4
    5
    6

    Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 5, p. 756, doi. 10.1111/bcpt.13990
    By:
    • Houlind, Morten Baltzer;
    • Hansen, Luise;
    • Iversen, Esben;
    • Rasmussen, Henrik Berg;
    • Larsen, Jens Borggaard;
    • Jørgensen, Steffen;
    • Dalhoff, Kim;
    • Damkier, Per;
    • Walls, Anne B.;
    • Vermehren, Charlotte;
    • Andersen, Trine Rune Høgh;
    • Kallemose, Thomas;
    • Christrup, Lona;
    • Westergaard, Niels
    Publication type:
    Article
    7

    Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 5, p. 643, doi. 10.1111/bcpt.13991
    By:
    • Voigt, Jens Hohwü;
    • Lauritsen, Katrine M.;
    • Pedersen, Steen Bønløkke;
    • Hansen, Troels K.;
    • Møller, Niels;
    • Jessen, Niels;
    • Laurenti, Marcello C.;
    • Man, Chiara Dalla;
    • Vella, Adrian;
    • Gormsen, Lars C.;
    • Søndergaard, Esben
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16